The signals initiated by skeletal muscle contraction and exercise involve several biochemical mechanisms both in the short- and long-time range that are under the control of thyroid hormones as genomic as well as nongenomic mechanisms. The effect of thyroid hormones on skeletal muscle has been studied both in cells in culture and in vivo. In L-6 myoblasts thyroid hormone increase intracellular calcium and pH. Administration of a single injection of thyroid hormone in rat i.p. leads to a rapid rise in T3 about 50-fold that peaked at 2 hours. The effect of this treatment was evaluated in signaling kinases, in particular on the phosphorylation of the p38MAPK pathway, and AMP-activated protein kinase. Both were activated and both can be a downstream target of the integrin αvβ3, the reported plasma membrane receptor for thyroid hormones. Contractile activity leads to mitochondrial biogenesis within skeletal muscle, which gives rise to signaling pathways leading to the expression of transcription factors. These are activated by a Ca2+-dependent release, p38 and AMP-activated protein kinase. The activated transcription factors such as nuclear respiratory factor 1, interact with the coactivator PGC-1α to stimulate the expression of nuclear genes encoding mitochondrial proteins. This sequence of events can be induced not only by physical exercise, but also by thyroid hormone (T3) treatment in vivo particularly in slow twitch skeletal muscle. In conclusion, the old statement that thyroid hormone helps to keep the steady state, is still valid, furthermore it contributes to a good performance of skeletal muscle as exercise does.

Incerpi, S., DE VITO, P., Pedersen, J.z., Luly, P. (2011). Extranuclear effects of thyroid hormones in skeletal muscle. IMMUNOLOGY, ENDOCRINE & METABOLIC AGENTS IN MEDICINAL CHEMISTRY, 11(3), 188-198 [10.2174/187152211796642819].

Extranuclear effects of thyroid hormones in skeletal muscle.

DE VITO, PAOLO;PEDERSEN, JENS ZACHO;LULY, PAOLO
2011-01-01

Abstract

The signals initiated by skeletal muscle contraction and exercise involve several biochemical mechanisms both in the short- and long-time range that are under the control of thyroid hormones as genomic as well as nongenomic mechanisms. The effect of thyroid hormones on skeletal muscle has been studied both in cells in culture and in vivo. In L-6 myoblasts thyroid hormone increase intracellular calcium and pH. Administration of a single injection of thyroid hormone in rat i.p. leads to a rapid rise in T3 about 50-fold that peaked at 2 hours. The effect of this treatment was evaluated in signaling kinases, in particular on the phosphorylation of the p38MAPK pathway, and AMP-activated protein kinase. Both were activated and both can be a downstream target of the integrin αvβ3, the reported plasma membrane receptor for thyroid hormones. Contractile activity leads to mitochondrial biogenesis within skeletal muscle, which gives rise to signaling pathways leading to the expression of transcription factors. These are activated by a Ca2+-dependent release, p38 and AMP-activated protein kinase. The activated transcription factors such as nuclear respiratory factor 1, interact with the coactivator PGC-1α to stimulate the expression of nuclear genes encoding mitochondrial proteins. This sequence of events can be induced not only by physical exercise, but also by thyroid hormone (T3) treatment in vivo particularly in slow twitch skeletal muscle. In conclusion, the old statement that thyroid hormone helps to keep the steady state, is still valid, furthermore it contributes to a good performance of skeletal muscle as exercise does.
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/09
English
Con Impact Factor ISI
AMP-activated protein kinase; glucose transport; integrin αvβ3; mitogen activated protein kinase; Na+/H+ exchanger; p38MAPK; peroxisome proliferator-activated receptor γ coactivator-1α
Incerpi, S., DE VITO, P., Pedersen, J.z., Luly, P. (2011). Extranuclear effects of thyroid hormones in skeletal muscle. IMMUNOLOGY, ENDOCRINE & METABOLIC AGENTS IN MEDICINAL CHEMISTRY, 11(3), 188-198 [10.2174/187152211796642819].
Incerpi, S; DE VITO, P; Pedersen, Jz; Luly, P
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/21124
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact